biomodal is hosting a webinar featuring Mike Stubbington analyzing the data from new duet mosaic products for liquid biopsy applications.

biomodal is an omics-based life sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solutions enable more epigenetic information from a single, low input DNA sample without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, resolved sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing. Recognised for our world-class innovation in "The Sunday Times 100 Tech 2026," which showcases the fastest growing UK tech companies, you can learn more at biomodal.com and follow us on LinkedIn.